Trial Profile
Comaprison between boceprever and telaprevir for the treatment of chronic hepatitis C genotype 1
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2015 New trial record